Literature DB >> 9133490

Strategies for treatment of generalized anxiety in the primary care setting.

E Schweizer1, K Rickels.   

Abstract

Generalized Anxiety Disorder (GAD) is a highly prevalent condition whose course of illness is often chronic in nature and fluctuating in severity. Pharmacotherapy options include the benzodiazepines, the azapirones, of which only buspirone is marketed at the present time, and the antidepressant imipramine. Buspirone is probably the treatment of choice when prolonged therapy is indicated because it does not produce physical dependence, dose not interact with alcohol, and does not cause psychomotor impairment. Dosing instructions for buspirone and guidelines for switching patients from benzodiazepines to buspirone are offered. Non-drug therapies such as interpersonal and cognitive therapies are often also found helpful in treating patients with GAD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133490

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

Review 1.  Psychological therapies for generalised anxiety disorder.

Authors:  V Hunot; R Churchill; M Silva de Lima; V Teixeira
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.

Authors:  Jorge Luiz Carrão; Leila Beltrami Moreira; Flávio Danni Fuchs
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-10       Impact factor: 5.270

3.  Pain adversely affects outcomes to a collaborative care intervention for anxiety in primary care.

Authors:  Natalia E Morone; Bea Herbeck Belnap; Fanyin He; Sati Mazumdar; Debra K Weiner; Bruce L Rollman
Journal:  J Gen Intern Med       Date:  2012-08-10       Impact factor: 5.128

4.  Symptomatic severity of PRIME-MD diagnosed episodes of panic and generalized anxiety disorder in primary care.

Authors:  Bruce L Rollman; Bea Herbeck Belnap; Sati Mazumdar; Fang Zhu; Kurt Kroenke; Herbert C Schulberg; M Katherine Shear
Journal:  J Gen Intern Med       Date:  2005-07       Impact factor: 5.128

5.  Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment.

Authors:  Alan J. Gelenberg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-04

6.  A Review of the Diagnosis, Pharmacologic Treatment, and Economic Aspects of Anxiety Disorders.

Authors:  Steven R. Arikian; Jack M. Gorman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.